GenomicDAO to empower billions of people to join forces for the advancement of Precision Medicine.
Genetica®, a leading AI biotech company, has launched the decentralized science platform GenomicDAO for Precision Medicine advancement. With the core technology - gene decoding chips, AI, and blockchain, GenomicDAO can empower billions to join forces.
Genetica® captured the Precision Medicine movement with over 100,000 genetic profiles through its proprietary gene decoding services using AI. Meanwhile, GenomicDAO breaks free from the centralization of modern medicine R&D by establishing a community for precision medicine initiatives, in which members can reap financial and medical benefits.
To develop products addressing health causes initiated by its community, GenomicDAO’s ultimate goal is to create genetic insights, personalized recommendations, and precision medicine drugs. Its platform will serve as the launchpad to bootstrap various precision medicine initiatives, followed by a dedicated subsidiary DAO.
Genetica® partnered with Illumina® & Thermo Fisher, two of the world’s leading genomics organizations, and has over 20 products in its portfolio from comprehensive healthcare to sports and early disease prevention. It was awarded The Best AI-Powered Genetic Testing Biotech Company by Global Health & Pharma and is advised by top scientists from world-renowned universities such as UCSF, Harvard, Stanford, and Cornell.
GenomicDAO has kicked off its first initiative – Stroke Prevention – with the official token listing set on February 20, 2023.
________________
About GenomicDAO
GenomicDAO is an AI-Powered DeSci Platform to advance Precision Medicine for Asians.
Decentralizing the Future of Modern Medicine
Linktree: https://linktr.ee/genomicdao
